Israel-based AI-powered drug simulation company QuantHealth has raised USD 15 million in Series A financing co-led by Bertelsmann Investments and Pitango HealthTech, with participation from existing investors Shoni Top Ventures and Nina Capital, among others. This brings the company's total funds raised to date to USD 20 million.

The funding will be used for the company's expansion, to enhance the product, and to broaden the platform's applications to include areas like regulatory assistance and initial R&D. 

QuantHealth employs AI technology that has been trained on a vast dataset to mimic clinical trials on a large scale. Its goal is to speed up, reduce risks, and enhance the efficiency of drug development. The company predicts that its AI technology can forecast the results of trials with an accuracy rate of 86%. QuantHealth supports Big Pharma companies, biotech companies, and CROs with its clinical trials.